# Olov Wiklund

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/olov-wiklund/

## Facts

| Field | Value |
| --- | --- |
| Citations | 66,574 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 77 |
| i10-index | 177 |
| Last Known Institution | Karolinska Institutet |
| OpenAlex ID | https://openalex.org/A5021240310 |
| ORCID iD | https://orcid.org/0000-0003-1074-2094 |
| Works | 261 |

## Researcher papers

- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-5/)
- [2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification/)
- [Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel](https://scholariq.org/papers/low-density-lipoproteins-cause-atherosclerotic-cardiovascular-disease-1-evidence/)
- [European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-4/)
- [ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias-the-task-force-for-the/)
- [Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society](https://scholariq.org/papers/familial-hypercholesterolaemia-is-underdiagnosed-and-undertreated-in-the-general/)
- [Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel](https://scholariq.org/papers/low-density-lipoproteins-cause-atherosclerotic-cardiovascular-disease/)
- [Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management](https://scholariq.org/papers/statin-associated-muscle-symptoms-impact-on-statin-therapy-european/)
- [Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society](https://scholariq.org/papers/homozygous-familial-hypercholesterolaemia-new-insights-and-guidance-for/)
- [Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment](https://scholariq.org/papers/familial-hypercholesterolaemia-in-children-and-adolescents-gaining-decades-of/)
- [Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine](https://scholariq.org/papers/fasting-is-not-routinely-required-for-determination-of-a-lipid-profile-clinical/)
- [ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)

## Researcher university

- [Karolinska Institutet](https://scholariq.org/institutions/karolinska-institutet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.